Jamie M Sperger - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jamie M Sperger

Showing results (21-30 of 33) with videos related to

Pageof 4

Sort By:

Oncogene|March 8, 2018

Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2021

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving ResistanceRana R McKay, Lucia Kwak, Jett P Crowdis, et al.

Molecular Oncology|February 19, 2021

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021

Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.

Molecular Oncology|February 22, 2025

Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.

Research Square|January 10, 2024

ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.

Nature Communications|October 14, 2025

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.

NPJ Precision Oncology|May 17, 2024

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017

Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.

Pageof 4

Search research articles

Showing results (21-30 of 33) with videos related to

Sort By:

Pageof 4

Oncogene|March 8, 2018

Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2021

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving ResistanceRana R McKay, Lucia Kwak, Jett P Crowdis, et al.

Molecular Oncology|February 19, 2021

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021

Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.

Molecular Oncology|February 22, 2025

Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.

Research Square|January 10, 2024

ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.

Nature Communications|October 14, 2025

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.

NPJ Precision Oncology|May 17, 2024

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017

Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.

Pageof 4